[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100578025":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":18,"responsibleParty":35,"collaborators":7,"id":37,"slug":38,"hasResults":39,"nctId":40,"briefTitle":41,"officialTitle":42,"acronym":43,"eligibilityCriteria":44,"healthyVolunteers":39,"sex":45,"minAge":46,"maxAge":7,"enrollmentInfo":47,"targetDuration":7,"studyType":50,"phases":7,"briefSummary":51,"conditions":52,"keywords":7,"overallStatus":21,"whyStopped":7,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":55,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":63},{"fullName":5,"class":6},"IRCCS San Raffaele Roma","OTHER",null,[9,14],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Domenica Le Pera, MD, PhD","CONTACT","+390652252344","domenica.lepera@sanraffaele.it",{"name":15,"role":11,"phone":16,"phoneExt":7,"email":17},"Lucia Gatta, PhD","+390652253440","lucia.gatta@sanraffaele.it",[19],{"facility":20,"status":21,"city":22,"state":23,"zip":24,"country":23,"countryCode":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"IRCCS San Raffaele","RECRUITING","Roma","Italy","00163","IT",{"type":27,"coordinates":28},"Point",[29,30],11.10642,44.99364,{"lat":30,"lon":29},[33],{"name":34,"role":11,"phone":12,"phoneExt":7,"email":13},"Domenica Le Pera, Md, PhD",{"type":36,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100578025","correlation-between-clinical-neurological-biomarkers-and-rehabilitation-outcome-100578025",false,"NCT06805929","Correlation Between Clinical Neurological Biomarkers and Rehabilitation Outcome","Correlation Study Between Clinical, Neurophysiological, and Neuroradiological Biomarkers and Rehabilitation Outcomes to Predict Functional Recovery After Stroke and Personalize Treatment.","PREVICTUS","Inclusion Criteria:\n\n* First stroke in the middle cerebral artery territory.\n* Ischemic or hemorrhagic stroke (7-30 days post-acute event).\n* Upper limb plegia or paresis.\n* Both genders, aged \\>18 years.\n* Ability to provide informed consent by the patient or caregiver\u002Fresponsible relative.\n\nExclusion Criteria:\n\n* Previous stroke.\n* Stroke in territories other than the middle cerebral artery.\n* Inability to provide informed consent.\n* Contraindications to TMS or MRI.\n* History of cancer in the past two years.\n* Presence of other neurological conditions interfering with biomarkers","ALL","18 Years",{"count":48,"type":49},300,"ESTIMATED","OBSERVATIONAL","Our study purpose is to evaluate the predictive power of various clinical, neurophysiological, and neuroimaging biomarkers-acquired and analyzed using advanced and integrated techniques-on motor functional recovery and disability post-stroke. The goal is to construct an integrated individual biomarker algorithm with a high predictive value for outcomes.",[53],"Stroke","2025-02-04",{"date":56,"type":57},"2025-02-07","ACTUAL",{"date":59,"type":57},"2020-06-15",{"date":61,"type":49},"2028-06-30",{"name":5,"class":6},1]